Sequential biological dosimetry after a single treatment with iodine-131 for differentiated thyroid carcinoma.
Radhia M’kacher(Genopole (France)), C Parmentier(Institut Gustave Roussy), A Gaussen, Nadine Béron‐Gaillard(Institut Gustave Roussy), B Aubert(Hôpital Lapeyronie), Martin Schlumberger(Université Paris-Saclay), Jean-Denis Légal
PubMed
March 1, 1997
Cited by 47
Related Papers
Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors.
|PubMed|2001|287
<i>SDHB</i> mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma
|International Journal of Cancer|2014|207
One-Year Progression-Free Survival of Therapy-Naive Patients With Malignant Pheochromocytoma and Paraganglioma
|The Journal of Clinical Endocrinology & Metabolism|2013|119
Current Concepts in the Management of Unilateral Recurrent Laryngeal Nerve Paralysis after Thyroid Surgery
|The Journal of Clinical Endocrinology & Metabolism|2005|113
A phase 1 study of LOXO-292, a potent and highly selective RET inhibitor, in patients with <i>RET</i>-altered cancers.
|Journal of Clinical Oncology|2018|104